Bio

Matt joined Downing in 2018, having qualified as a Chartered Accountant at Deloitte focusing on life science clients and worked at Berenberg in the healthcare equity research team. Matt is responsible for originating, transacting and monitoring investment opportunities for its Life Sciences and Healthcare investments. Matt holds a degree in Biotechnology from the University of Edinburgh.